Abstract
The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol. Patients were assessed by angina diaries and exercise testing. Slow-release nifedipine was as effective as nifedipine in the treatment of these patients, both alone and in combination with atenolol.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Antman E. M., Stone P. H., Muller J. E., Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med. 1980 Dec;93(6):875–885. doi: 10.7326/0003-4819-93-6-875. [DOI] [PubMed] [Google Scholar]
- Bonaduce D., Canonico V., Mazza F., Nicolino A., Ferrara N., Chiariello M., Condorelli M. Evaluation of the efficacy of slow-release nifedipine in systemic hypertension by ambulatory intraarterial blood pressure monitoring. J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):145–151. doi: 10.1097/00005344-198501000-00024. [DOI] [PubMed] [Google Scholar]
- Deanfield J., Wright C., Fox K. Treatment of angina pectoris with nifedipine: importance of dose titration. Br Med J (Clin Res Ed) 1983 May 7;286(6376):1467–1470. doi: 10.1136/bmj.286.6376.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Findlay I. N., MacLeod K., Ford M., Gillen G., Elliott A. T., Dargie H. J. Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J. 1986 Mar;55(3):240–245. doi: 10.1136/hrt.55.3.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Findlay I. N., MacLeod K., Gillen G., Elliott A. T., Aitchison T., Dargie H. J. A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. Br Heart J. 1987 Apr;57(4):336–343. doi: 10.1136/hrt.57.4.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
- Lynch P., Dargie H., Krikler S., Krikler D. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br Med J. 1980 Jul 19;281(6234):184–187. doi: 10.1136/bmj.281.6234.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zylber-Katz E., Koren G., Granit L., Levy M. Bioavailability of nifedipine: a comparison between two preparations. Biopharm Drug Dispos. 1984 Apr-Jun;5(2):109–115. doi: 10.1002/bdd.2510050204. [DOI] [PubMed] [Google Scholar]